ASP Isotopes (NASDAQ:ASPI) Shares Gap Up - Still a Buy?

ASP Isotopes Inc. (NASDAQ:ASPI - Get Free Report) shares gapped up before the market opened on Thursday . The stock had previously closed at $8.17, but opened at $8.53. ASP Isotopes shares last traded at $8.75, with a volume of 1,999,896 shares changing hands.

Wall Street Analysts Forecast Growth

Separately, Canaccord Genuity Group raised their price target on ASP Isotopes from $8.50 to $11.00 and gave the stock a "buy" rating in a report on Wednesday, May 21st.

ASP Isotopes Price Performance

The firm's fifty day moving average is $7.69 and its two-hundred day moving average is $5.99. The company has a market cap of $809.44 million, a P/E ratio of -15.82 and a beta of 3.35. The company has a debt-to-equity ratio of 0.80, a quick ratio of 7.17 and a current ratio of 7.21.

Institutional Investors Weigh In On ASP Isotopes

Several institutional investors have recently bought and sold shares of ASPI. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in ASP Isotopes by 9.4% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 31,613 shares of the company's stock worth $148,000 after buying an additional 2,709 shares in the last quarter. Price T Rowe Associates Inc. MD raised its position in shares of ASP Isotopes by 14.6% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 21,646 shares of the company's stock valued at $99,000 after buying an additional 2,757 shares during the last quarter. Russell Investments Group Ltd. grew its stake in ASP Isotopes by 56.3% during the fourth quarter. Russell Investments Group Ltd. now owns 10,221 shares of the company's stock worth $46,000 after buying an additional 3,682 shares during the period. SBI Securities Co. Ltd. grew its holdings in ASP Isotopes by 84.8% during the 1st quarter. SBI Securities Co. Ltd. now owns 9,370 shares of the company's stock valued at $44,000 after purchasing an additional 4,299 shares in the last quarter. Finally, Rhumbline Advisers boosted its holdings in shares of ASP Isotopes by 8.2% in the 1st quarter. Rhumbline Advisers now owns 65,326 shares of the company's stock valued at $306,000 after buying an additional 4,963 shares during the period. 16.80% of the stock is currently owned by institutional investors and hedge funds.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.